These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 14551748)

  • 21. Correlation of GLUT-1 overexpression, tumor size, and depth of invasion with 18F-2-fluoro-2-deoxy-D-glucose uptake by positron emission tomography in colorectal cancer.
    Gu J; Yamamoto H; Fukunaga H; Danno K; Takemasa I; Ikeda M; Tatsumi M; Sekimoto M; Hatazawa J; Nishimura T; Monden M
    Dig Dis Sci; 2006 Dec; 51(12):2198-205. PubMed ID: 17080242
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnostic usefulness of ¹⁸F-FAMT PET and L-type amino acid transporter 1 (LAT1) expression in oral squamous cell carcinoma.
    Nobusawa A; Kim M; Kaira K; Miyashita G; Negishi A; Oriuchi N; Higuchi T; Tsushima Y; Kanai Y; Yokoo S; Oyama T
    Eur J Nucl Med Mol Imaging; 2013 Oct; 40(11):1692-700. PubMed ID: 23801167
    [TBL] [Abstract][Full Text] [Related]  

  • 23. FDG-PET for prediction of tumour aggressiveness and response to intra-arterial chemotherapy and radiotherapy in head and neck cancer.
    Kitagawa Y; Sano K; Nishizawa S; Nakamura M; Ogasawara T; Sadato N; Yonekura Y
    Eur J Nucl Med Mol Imaging; 2003 Jan; 30(1):63-71. PubMed ID: 12483411
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biologic correlates of intratumoral heterogeneity in 18F-FDG distribution with regional expression of glucose transporters and hexokinase-II in experimental tumor.
    Zhao S; Kuge Y; Mochizuki T; Takahashi T; Nakada K; Sato M; Takei T; Tamaki N
    J Nucl Med; 2005 Apr; 46(4):675-82. PubMed ID: 15809491
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glut-1 and hexokinase expression: relationship with 2-fluoro-2-deoxy-D-glucose uptake in A431 and T47D cells in culture.
    Aloj L; Caracó C; Jagoda E; Eckelman WC; Neumann RD
    Cancer Res; 1999 Sep; 59(18):4709-14. PubMed ID: 10493529
    [TBL] [Abstract][Full Text] [Related]  

  • 26. P-glycoprotein expression is associated with FDG uptake and cell differentiation in patients with untreated lung cancer.
    Higashi K; Ueda Y; Ikeda R; Kodama Y; Guo J; Matsunari I; Oguchi M; Tonami H; Katsuda S; Yamamoto I
    Nucl Med Commun; 2004 Jan; 25(1):19-27. PubMed ID: 15061261
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High correlations between primary tumours and loco-regional metastatic lymph nodes in non-small-cell lung cancer with respect to glucose transporter type 1-mediated 2-deoxy-2-F18-fluoro-D-glucose uptake.
    Nguyen XC; So Y; Chung JH; Lee WW; Park SY; Kim SE
    Eur J Cancer; 2008 Mar; 44(5):692-8. PubMed ID: 18314327
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 18F-fluoromisonidazole PET uptake is correlated with hypoxia-inducible factor-1α expression in oral squamous cell carcinoma.
    Sato J; Kitagawa Y; Yamazaki Y; Hata H; Okamoto S; Shiga T; Shindoh M; Kuge Y; Tamaki N
    J Nucl Med; 2013 Jul; 54(7):1060-5. PubMed ID: 23699668
    [TBL] [Abstract][Full Text] [Related]  

  • 29. No relationship between 18F-fluorodeoxyglucose positron emission tomography and expression of Glut-1 and -3 and hexokinase I and II in high-grade glioma.
    Charnley N; Airley R; Du Plessis D; West C; Brock C; Barnett C; Matthews J; Symonds K; Bottomly M; Swindell R; Price P
    Oncol Rep; 2008 Sep; 20(3):537-42. PubMed ID: 18695903
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The relationship between GLUT-1 and vascular endothelial growth factor expression and 18F-FDG uptake in esophageal squamous cell cancer patients.
    Kobayashi M; Kaida H; Kawahara A; Hattori S; Kurata S; Hayakawa M; Hirose Y; Uchida M; Kage M; Fujita H; Hayabuchi N; Ishibashi M
    Clin Nucl Med; 2012 May; 37(5):447-52. PubMed ID: 22475893
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 18F-FDG-PET of musculoskeletal tumors: a correlation with the expression of glucose transporter 1 and hexokinase II.
    Hamada K; Tomita Y; Qiu Y; Zhang B; Ueda T; Myoui A; Higuchi I; Yoshikawa H; Aozasa K; Hatazawa J
    Ann Nucl Med; 2008 Oct; 22(8):699-705. PubMed ID: 18982473
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dissociation of glucose tracer uptake and glucose transporter distribution in the regionally ischaemic isolated rat heart: application of a new autoradiographic technique.
    Southworth R; Dearling JL; Medina RA; Flynn AA; Pedley RB; Garlick PB
    Eur J Nucl Med Mol Imaging; 2002 Oct; 29(10):1334-41. PubMed ID: 12271416
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationship between glucose transporter, hexokinase and FDG-PET in esophageal cancer.
    Tohma T; Okazumi S; Makino H; Cho A; Mochiduki R; Shuto K; Kudo H; Matsubara K; Gunji H; Ochiai T
    Hepatogastroenterology; 2005; 52(62):486-90. PubMed ID: 15816463
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ¹⁸F-FAMT uptake correlates with tumor proliferative activity in oral squamous cell carcinoma: comparative study with ¹⁸F-FDG PET and immunohistochemistry.
    Miyashita G; Higuchi T; Oriuchi N; Arisaka Y; Hanaoka H; Tominaga H; Morita S; Miyakubo M; Ishikita T; Nakasone Y; Negishi A; Yokoo S; Endo K
    Ann Nucl Med; 2010 Oct; 24(8):579-84. PubMed ID: 20652456
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SUVmax of FDG-PET correlates with the effects of neoadjuvant chemoradiotherapy for oral squamous cell carcinoma.
    Miyawaki A; Ikeda R; Hijioka H; Ishida T; Ushiyama M; Nozoe E; Nakamura N
    Oncol Rep; 2010 May; 23(5):1205-12. PubMed ID: 20372831
    [TBL] [Abstract][Full Text] [Related]  

  • 36. FDG uptake in primary squamous cell carcinoma of the head and neck. The relationship between overexpression of glucose transporters and hexokinases, tumour proliferation and apoptosis.
    Deron P; Vangestel C; Goethals I; De Potter A; Peeters M; Vermeersch H; Van de Wiele C
    Nuklearmedizin; 2011; 50(1):15-21. PubMed ID: 21052609
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationship between FDG uptake and expressions of glucose transporter type 1, type 3, and hexokinase-II in Reed-Sternberg cells of Hodgkin lymphoma.
    Shim HK; Lee WW; Park SY; Kim H; Kim SE
    Oncol Res; 2009; 17(7):331-7. PubMed ID: 19408578
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography in gastric carcinoma: relation to histological subtypes, depth of tumor invasion, and glucose transporter-1 expression.
    Yamada A; Oguchi K; Fukushima M; Imai Y; Kadoya M
    Ann Nucl Med; 2006 Nov; 20(9):597-604. PubMed ID: 17294670
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship between retention index in dual-phase (18)F-FDG PET, and hexokinase-II and glucose transporter-1 expression in pancreatic cancer.
    Higashi T; Saga T; Nakamoto Y; Ishimori T; Mamede MH; Wada M; Doi R; Hosotani R; Imamura M; Konishi J
    J Nucl Med; 2002 Feb; 43(2):173-80. PubMed ID: 11850481
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The maximum uptake of (18)F-deoxyglucose on positron emission tomography scan correlates with survival, hypoxia inducible factor-1alpha and GLUT-1 in non-small cell lung cancer.
    van Baardwijk A; Dooms C; van Suylen RJ; Verbeken E; Hochstenbag M; Dehing-Oberije C; Rupa D; Pastorekova S; Stroobants S; Buell U; Lambin P; Vansteenkiste J; De Ruysscher D
    Eur J Cancer; 2007 Jun; 43(9):1392-8. PubMed ID: 17512190
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.